1. Introduction
===============

Membrane fusion is the prerequisite event that allows enveloped viruses, some of which are linked to emerging infectious diseases such as avian influenza, severe acute respiratory syndrome, and acquired immunodeficiency syndrome (AIDS), to enter their host cells. Among these emerging diseases, AIDS has become a global threat to human health. The discovery of a membrane fusion inhibitor has made HIV-1 Env an important target for anti-HIV-1 chemotherapy ([@bib5], [@bib6], [@bib7], [@bib21], [@bib25]). Recently, a new class of inhibitor that blocks the interaction between Env and its co-receptor, CCR5, has been developed ([@bib23]). A simple phenotyping method of Env-mediated membrane fusion will facilitate progress in the development of new inhibitors or in the evaluation of drug-resistant mutants ([@bib20]).

A phenotyping method of HIV-1 Env requires a system that generates a measurable signal upon membrane fusion either in a cell--cell or virus--cell system. The methods described employ materials, such as visible dyes, transcription factors, and self-complementing enzyme fragments, that produce a signal when they transfer from one compartment to another via membrane fusion ([@bib1], [@bib2], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib16], [@bib17], [@bib19], [@bib22]).

The development of a versatile, cell-based membrane fusion assay system is described in this report. The system employs a modified green fluorescent protein (GFP), split GFP (spGFP), which has been engineered to have the capacity for self-assembly ([@bib3]). The pleckstrin homology (PH) domain ([@bib15]) was fused at the N-termini of spGFPs so as to focus the signal in the membrane regions. These spGFPs become fluorescent only when they have reassociated with each other ([@bib3]) during the membrane fusion. Unlike an enzyme-based assay, this spGFP system allows real-time monitoring of the membrane fusion process without any additional substrates.

2. Materials and methods
========================

2.1. Construction of expression vectors
---------------------------------------

The PH domain based on human phospholipase Cδ was synthesized by assembling 10 oligonucleotides, each containing 79 nucleotides. The oligonucleotides were combined and assembled by PCR (94 °C for 30 s, 50 °C for 30 s, 72 °C for 40 s for 30 cycles). Similarly, 30 oligonucleotides, which overlapped each other with 18 bases at the both ends, were used to assemble the optimized GFP gene, named GFPopt~1--11~. The primary sequences of the PH domain and GFPopt~1--11~ are shown in [Fig. 1](#fig1){ref-type="fig"}A. Both amplicons were cloned and sequenced in pCR4Blunt-TOPO (Invitrogen, Carlsbad, USA). GFPopt~1--11~ was split into GFP~1--10~ (1--642 base pairs) and GFP~11~ (643--696 base pairs), at a point between the 10th and 11th β-sheets of the GFP. The subscripts 1--10 and 11 reflect this location. The PH-GFP~1--10~ and PH-GFP~11~ genes were generated by combining the PH domain gene with the spGFP genes. These genes were then cloned to pdEGFP, which was constructed by deleting the EGFP gene in pEGFP-N2 (BD Biosciences Clontech, Palo Alto, USA) ([Fig. 1](#fig1){ref-type="fig"}B). The expression vector for each protein was named by adding pd in front of the target protein, such as pdPH-GFP~1--10~.Fig. 1Engineered proteins and expression vectors. (A) The amino acid and nucleotide sequences of PH domain and GFPopt~1--11~ were shown. The amino acid residue was shown using the single-letter abbreviations. The split point between GFP~1--10~ and GFP~11~ is indicated by the arrow in GFPopt~1--11~. (B) (upper panel) The expression vector for spGFPs. MCS: multiple cloning site; spGFP: the insertion point of spGFP; *Kan*/*NeoR*: kanamycin/neomycin resistance gene. (Lower panel) The different spGFPs. PH: pleckstrin homology domain. The restriction sites that were used are indicated. (C) (upper panel) The HIV-1 envelope expression vector, pNHcRedEluc. pCMV: human cytomegalovirus promoter, NLS: nuclear-localization signal, HcRed: a far-red fluorescent protein isolated from *Heteractis crispa*, f-Luc: firefly luciferase, MSD: membrane-spanning domain, *AmpR*: ampicillin resistance gene. (Lower panel) Primary structures of the MSDs used. WT: wild type, GpA: glycophorin A, VSV-G: vesicular stomatitis virus G protein. The predicted MSD regions are capitalized.

The FLAG tag sequence was added to the 3′-termini of the spGFP genes by using a 3′-primer that included the FLAG tag sequence during PCR. A new HIV-1 Env-expression vector called pNHcRedEluc, a derivative of pElucEnv ([@bib18]), was constructed by replacing the gene for EGFP with that of a tandem red fluorescent protein; HcRed (Evrogen, Moscow, Russia). This was preceded by a nuclear-localizing signal ([Fig. 1](#fig1){ref-type="fig"}C). Thus the nuclei of transfected cells became red. The transfection efficiency could then be measured by firefly luciferase activity. The pNHcRedElucΔNB vector in which most of the env gene had been deleted was prepared as a negative control.

2.2. Cell cultures and transfection
-----------------------------------

The 293FT (Invitrogen, Carlsbad, USA) and 293CD4 ([@bib18]) cells were maintained in Dulbecco\'s modified Eagle\'s medium (DMEM, Sigma, St. Louis, USA) supplemented with 10% fetal bovine serum (Hyclone, Logan, USA). The 293FT cells were cultured with 500 μg/ml of Geneticin (Gibco, Grand Island, USA), as recommended by the manufacturer. Transient transfection was accomplished using Fugene HD (Roche, Indianapolis, USA). Stable cell lines expressing PH-GFP~1--10~ were established after transfecting 293CD4 cells with pdPH-GFP~1--10~ by electroporation (Biorad GenePulsar, Hercules, USA). Transfected cells were selected with 700 μg/ml of Geneticin in DMEM.

2.3. Fusion assay
-----------------

The spGFP-mediated fusion assay was performed as follows. The expression vectors pNHcRedEluc and pdPH-GFP~11~ were transfected into 293FT cells. The transfected 293FT cells were overlaid with 293CD4 cells which were transfected transiently or permanently with vector pdPH-GFP~1--10~. In the case of transient transfection, the mixing of cells was started at 42 h after transfection. Fusion was monitored in real-time using an IN Cell Analyzer 1000 (GE Healthcare, Uppsala, Sweden) or was observed using a confocal microscope (Olympus FluoView FV1000, Tokyo, Japan) that examined fixed cells (4% paraformaldehyde) at designated time points.

The fusion assay using the mixing of the two different fluorescent proteins expressed in the Env(+)- and receptor(+) cells, respectively as an indicator was carried out as follows. The pElucEnv ([@bib18]) was transfected into 293FT cells to make Env(+) cells. Because pElucEnv expressed both the HIV-1 Env and GFP proteins, this generated "green" Env(+) cells. Meanwhile the expression vector for DsRed (Clontech/Takara, Otsu, Japan) was transfected into 293CD4 cells to generate "red" receptor(+) cells. These two types of cells were co-cultured and the extent of the fusion was monitored by the redistribution of the green and red signals by microscopy.

The inhibitor C34 was used to show the specificity of the new fusion assay. According to the previous study ([@bib14]), two different concentrations, 12 nM and 150 nM in a final concentration, of the peptide inhibitor, C34, was added at the beginning of the co-culture. The IC50 value of the C34 peptide was about 12 nM and more than 90% inhibition was observed with the concentration of 150 nM ([@bib14]). The cells were fixed and examined after 2.5 h of co-culture and analyzed as described above.

2.4. Protein analysis
---------------------

Sample preparation and immunoblotting were done as described previously ([@bib18]). Anti-FLAG antibody (Sigma, Saint Louis, USA) and anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, USA) were used as primary antibodies for the analysis of GFP~11~ and GFP~1--10~, respectively. Chemiluminescence signals were detected using an LAS-3000Lite (Fujifilm, Tokyo, Japan).

2.5. Immunofluorescence assay
-----------------------------

Transfected cells were fixed in an acetone:methanol solution (1:1) for 15 min at room temperature and stained with an anti-FLAG antibody (3 μg/ml) for 40 min at 30 °C. A secondary antibody, labeled with Alexa Fluor 555 (Invitrogen, Carlsbad, USA), was used. The fluorescent signal was observed using a confocal microscope (Olympus FluoView FV1000, Tokyo, Japan).

3. Results
==========

3.1. Expression of modified spGFPs
----------------------------------

### 3.1.1. Immunoblotting analysis

The expression vectors containing different spGFPs shown in [Fig. 1](#fig1){ref-type="fig"}B were transfected into the cells and the expressed proteins were then analyzed by immunoblotting. When probed with an anti-GFP antibody, GFP~1--10~ and PH-GFP~1--10~ were detected as approximately 25 kDa and 40 kDa bands, respectively ([Fig. 2](#fig2){ref-type="fig"}A). The observed molecular weights were consistent with those expected from the amino acid sequences. The cells transfected with pEGFP-N2 (BD Biosciences Clontech) were included as a positive control ([Fig. 2](#fig2){ref-type="fig"}A, EGFP lane). As for GFP~11~, an anti-GFP antibody failed to detect any band (data not shown). A FLAG tag was added to GFP~11~ with and without the PH domain because this failure could have been caused by the absence of anti-GFP\'s epitope in the seventeen-amino-acid-long GFP~11~ portion. When probed with an anti-FLAG antibody, a band of 22 kDa was detected for PH-GFP~11~-FLAG but not for GFP~11~-FLAG ([Fig. 2](#fig2){ref-type="fig"}B). This result suggested that GFP~11~, as only a seventeen-amino-acid-long peptide, was unstable without the PH domain.Fig. 2The spGFPs expressed in the transfected cells. (A) Immunoblotting analysis of 293CD4 cells transfected with GFP~1--10~ and PH-GFP~1--10~ expression vectors and probed with an anti-GFP antibody. Cells transfected with pEGFP-N2 (BD Biosciences Clontech) were included as a positive control (EGFP lane). (B) The proteins expressed in 293FT cells transfected with the GFP~11~-FLAG or the PH-GFP~11~-FLAG expression vectors were probed with an anti-FLAG monoclonal antibody. Mock: the mock transfected cells.

### 3.1.2. Immunofluorescence analysis

Immunofluorescence analysis was used to examine the intracellular localization of the spGFPs. The GFP~1--10~ distributed throughout the cell, but with the PH domain attached, the PH-GFP~1--10~ localized to the periphery of the transfected cells ([Fig. 3](#fig3){ref-type="fig"}A). The expression of FLAG-tagged GFP~11~ ([Fig. 3](#fig3){ref-type="fig"}B, top) was not detected. This finding is consistent with the results of immunoblotting ([Fig. 2](#fig2){ref-type="fig"}B). However, FLAG-tagged PH-GFP~11~ was detectable at the cell periphery ([Fig. 3](#fig3){ref-type="fig"}B, middle). Without the FLAG tag, PH-GFP~11~ showed no signal with anti-FLAG antibody ([Fig. 3](#fig3){ref-type="fig"}B, bottom).Fig. 3Intracellular localization of spGFPs expressed with pdExpression vectors. (A) Immunofluorescence assay of GFP~1--10~ or PH-GFP~1--10~-transfected cells using an anti-GFP antibody. Mock: mock transfected cells; BF: bright field view; Alexa555: the Alexa555-derived signal. (B) Immunofluorescence assay of GFP~11~-FLAG, PH-GFP~11~-FLAG, and PH-GFP~11~-transfected cells using anti-FLAG antibody. The abbreviations used are the same as for (A). (C) Co-transfection of PH-GFP~1--10~ with PH-GFP~11~ and GFP~11~ and of GFP~1--10~ with PH-GFP~11~ and GFP~11~. (D) Single transfection of different spGFPs. BF: bright field view; GFP: the GFP signal.

3.2. Recovery of GFP function by reassociation of spGFPs
--------------------------------------------------------

Next, pairs of the spGFPs were co-transfected into 293FT cells and their outcome was examined ([Fig. 3](#fig3){ref-type="fig"}C). Consistent with the data shown in [Fig. 2](#fig2){ref-type="fig"}, PH-GFP~11~, but not free GFP~11~, was able to generate a green signal ([Fig. 3](#fig3){ref-type="fig"}C). When PH-GFP~11~ was co-transfected with GFP~1--10~, a homogenous green signal was observed. This data suggests that the reassociation of two split GFPs could take place before they are localized to the plasma membrane. With the pair of PH-GFP~1--10~ and PH-GFP~11~, most of the green signal was detected in the rim of the co-transfected cells ([Fig. 3](#fig3){ref-type="fig"}C). As expected, neither the spGFPs nor the PH-spGFPs alone showed any fluorescence ([Fig. 3](#fig3){ref-type="fig"}D).

3.3. Membrane fusion assay using spGFPs
---------------------------------------

### 3.3.1. Analysis of the wild type HIV-1 Env-mediated fusion

PH-spGFPs was used for the analysis of membrane fusion induced by HIV-1 Env. For this, the 293FT cells were transfected with pNHcRedEluc and pdPH-GFP~11~ and then co-cultured with the 293CD4 cells that were stably expressing PH-GFP~1--10~. The green signal was observed at the plasma membrane surrounding several red nuclei ([Fig. 4](#fig4){ref-type="fig"}A). The red nuclei were derived from the 293FT cells expressing Env as pNHcRedEluc expressed the nuclear-localizing HcRed proteins. The unique localization of green signal in the membrane region made it easy to differentiate the real signal from the non-specific autofluorescence background. Furthermore, the non-envelope-mediated spontaneous fusions, if they occurred, could be ruled out by the absence of red nuclei in the syncytia. This result indicates that the simultaneous use of pNHcRedEluc and spGFPs allows us to monitor membrane fusion directly without the addition of dyes or substrates.Fig. 4Generation of the green fluorescent signal upon membrane fusion. Cell fusion between envelope- and receptor-expressing cells that harbor respective spGFP expression vectors were observed using a confocal microscope and IN Cell Analyzer. The HcRed signal was generated from the cells transfected with the expression vector for envelope and HcRed genes ([Fig. 1](#fig1){ref-type="fig"}C). (A) Detailed image of the localization of spGFPs and HcRed. BF indicates bright field; GFP: the green fluorescence signal; Merge: the merged images of GFP, HcRed, and BF. (B) The effect of the specific inhibitor and comparison with the fluorescent proteins-mixing assay. The specific inhibitor of the HIV-1 Env-mediated membrane fusion, C34, was used in the spGFP assay (left) and the conventional fluorescent protein-mixing assay (right). The final concentration of the inhibitor was indicated in nM. In the fluorescent protein-mixing assay (right), Env(+)-293FT cells expressing GFP and the receptor(+)-293CD4 cells expressing DsRed were co-cultured. Fused cells are seen as both GFP and DsRed signal-positive cells. (C) Comparison of the frequency of membrane fusion events between wild type (WT) and its MSD mutants (GpA and VSV-G) (details are in [Fig. 1](#fig1){ref-type="fig"}C). ΔNB indicates Env-deleted pNHcRedEluc. (D) The time-course analyses. Arrowheads indicate the regions of observed GFP signal. The time after co-culture is indicated in the upper left of each image.

### 3.3.2. Analysis of HIV-1 Env-mediated fusion using an inhibitor and Env mutants

The specificity of the spGFP assay was examined by using the known inhibitor of the HIV-1 Env-mediated membrane fusion, C34 ([@bib24]). The C34 peptide is known to inhibit the formation of 6-helix bundle. Two different concentrations, 12 nM (IC50) and 150 nM (IC90) ([@bib14]), were tested in spGFP fusion assays. For a comparison, in addition to the spGFP assay, the fusion assay using the Env(+)- or receptor(+)-cells expressing GFP and DsRed, respectively was used. In the spGFP assay, the number of the GFP signal-positive cells was decreased in a dose-dependent manner ([Fig. 4](#fig4){ref-type="fig"}B, left column). In a parallel assay, the number of the fused cells indicated by the presence of the both GFP and RFP signals in the fused cells was decreased similarly ([Fig. 4](#fig4){ref-type="fig"}B, right panel). The new spGFP assay was much easier to monitor, because the green signal was only observed when the actual fusion took place. In a conventional method relying on the mixture or redistribution of the two colors was more time consuming, because each cell has to be scored for the presence of either or both colors.

The previously described fusion-inefficient mutant Env that carries the mutation in the membrane-spanning domain (MSD) ([Fig. 1](#fig1){ref-type="fig"}C, lower panel) ([@bib18]) was also analyzed. Consistent with previous data ([@bib18]), the MSD mutants showed the fusion events but less frequently, as exemplified by the lower number of cells bearing the green signal ([Fig. 4](#fig4){ref-type="fig"}C).

### 3.3.3. Real-time membrane fusion assay

The membrane fusion in a real-time manner using spGFP system was monitored with an IN Cell Analyzer 1000. The green signal derived from the reassociated spGFPs gradually increased in the number and intensity over the observation period ([Fig. 4](#fig4){ref-type="fig"}D). When T7 RNA polymerase transfer assay was applied ([@bib18]), a corresponding increase in the reading of the reporter enzyme was observed (data not shown). Using the transient transfection system, we performed several tests to determine the timing needed to detect the green signal. Sometimes the signal was detected as early as 30 min after co-culturing. A more reliable result, however, was obtained after more than 1 h co-cultivation.

4. Discussion
=============

A cell-based assay system of membrane fusion that uses spGFP has been developed. It was found that the PH domain not only localizes the signal resulting from the spGFPs reassociated to the membrane but also aids the stable expression of GFP~11~.

The new spGFP-mediated system is cost- and labor-efficient. First, the same living co-cultured cells can be monitored for real-time monitoring over a prolonged period ([Fig. 4](#fig4){ref-type="fig"}D). Second, the reassociated spGFPs will produce a measurable signal without any additional reagents. The dye-mediated fusion assay requires preloading of dyes before the fusion reaction ([@bib2]). A quantitative fusion assay using enzymes, either as pre-expressed self-complementing enzyme fragments or as induced reporter enzymes, requires the addition of enzyme substrates to monitor the processes ([@bib4], [@bib11], [@bib13]). Furthermore, if a particular substrate is membrane impermeable, continuous monitoring of the same sample is impossible because the cells have to be lysed for the assay.

Simple assay systems described in this study are suitable for high-throughput analyses. The combination of dye-transfer and fluorescence-activated cell sorting can achieve this ([@bib12], [@bib17]). However, the system reported in this study is much simpler than these methods because it generates the detectable signal only when fusion actually occurs. In the dye-transfer assay or similar "color"-mixing assay shown in [Fig. 4](#fig4){ref-type="fig"}B, one has to discriminate the simple aggregation from real fusion because the dye signals are persistent throughout the assay.

As shown in the [Fig. 4](#fig4){ref-type="fig"}C, the lower incidence of membrane fusion induced by mutant Envs was detected as visible foci with the spGFP system. If one can clone the envelope genes from clinical samples into an appropriate expression vector, this system may be useful for detecting a minor population of Env that possesses the different co-receptor usage. Such a tropism assay can be easily adapted by using CCR5/CD4+ cells together with CXCR4/CD4+ cells. Similar identification of fusion foci can be achieved if GFP is used as a reporter gene in a transcriptional factor transfer assay, such as T7 RNA polymerase or Tat ([@bib1], [@bib9], [@bib16], [@bib22]), but the need for de novo transcription/translation steps may result in a longer lag time for signal generation. Of course, membrane fusion by viruses other than HIV-1 can be monitored easily.

This spGFP-based system does not require on-going transcription/translation steps during membrane fusion. Therefore, when the tag for a different intracellular compartments is applied, the system can be used to detect communication between two compartments in the cell, such as that which occurs in vesicular transport. The application of the spGFP in other biological systems has been described previously ([@bib8]).

This work was supported by a contract research fund from the Ministry of Education, Culture, Sports, Science and Technology of Japan for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases. We thank Dr. Kunito Yoshiike for his critical reading of the manuscript. We also thank A.M. Menting, an editorial consultant, for help in the preparation of the manuscript.
